Approval · Notice of Compliance 3253 · 1997
PRANDASE: Notice of Compliance 3253
Issued April 17, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3253
- Date
- April 17, 1997
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: in combination with sulfonylurea
- Therapeutic class
- Oral antidiabetic agent, alpha-glucosidase inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PRANDASE | Not yet assigned | — |